LOS greater for patients with CDCC 2 or 3. »
03/29/22

ORR of osimertinib in patients with liver metastases significantly attenuated. »
06/14/22

AST able to be safely administered in clinical setting. »
06/13/22

Risk model closely associated with regulation of immune infiltration as well as TME. »
06/13/22

Cancer survivors who met more of health behavior guidelines reported higher general health. »
06/13/22

Data elucidate diet-microbe interactions in CRC patients. »
06/14/22

Type II MET-TKI foretinib may be appropriate second-line treatment for NSCLC. »
06/11/22

Cytokine profiling and RNA-sequencing data analysis revealed NB cells as main source of MIF in BM. »
06/17/22

Level of cell-free miR-182-5p in plasma samples from BC patients could be clue for screening BC patients. »
06/17/22

First reported estimation of predictive accuracy derived from combining chemosensitivity and tumor gene expression. »
06/16/22